<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
                      "http://www.w3.org/TR/REC-html40/loose.dtd">
<HTML>
<HEAD>
<TITLE>extropians: Re: Pleconaril</TITLE>
<META NAME="Author" CONTENT="Joe E. Dees (joedees@bellsouth.net)">
<META NAME="Subject" CONTENT="Re: Pleconaril">
</HEAD>
<BODY BGCOLOR="#FFFFFF" TEXT="#000000">
<H1>Re: Pleconaril</H1>
<!-- received="Mon Jan 17 02:40:10 2000" -->
<!-- isoreceived="20000117094010" -->
<!-- sent="Mon, 17 Jan 2000 03:43:19 -0600" -->
<!-- isosent="20000117094319" -->
<!-- name="Joe E. Dees" -->
<!-- email="joedees@bellsouth.net" -->
<!-- subject="Re: Pleconaril" -->
<!-- id="200001170940.EAA09717@mail4.lig.bellsouth.net" -->
<!-- inreplyto="3883485b0.4821@ilr.genebee.msu.su" -->
<STRONG>From:</STRONG> Joe E. Dees (<A HREF="mailto:joedees@bellsouth.net?Subject=Re:%20Pleconaril&In-Reply-To=&lt;200001170940.EAA09717@mail4.lig.bellsouth.net&gt;"><EM>joedees@bellsouth.net</EM></A>)<BR>
<STRONG>Date:</STRONG> Mon Jan 17 2000 - 02:43:19 MST
<P>
<!-- next="start" -->
<UL>
<LI><STRONG>Next message:</STRONG> <A HREF="0883.html">Anders Sandberg: "Re: Creating new states"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="0881.html">Robert J. Bradbury: "Pleconaril"</A>
<LI><STRONG>In reply to:</STRONG> <A HREF="0881.html">Robert J. Bradbury: "Pleconaril"</A>
<!-- nextthread="start" -->
<LI><STRONG>Next in thread:</STRONG> <A HREF="0904.html">Eliezer S. Yudkowsky: "Re: Pleconaril"</A>
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#882">[ date ]</A>
<A HREF="index.html#882">[ thread ]</A>
<A HREF="subject.html#882">[ subject ]</A>
<A HREF="author.html#882">[ author ]</A>
</UL>
<HR NOSHADE><P>
<!-- body="start" -->
<P>
From:           	<A HREF="mailto:bradbury@ilr.genebee.msu.su?Subject=Re:%20Pleconaril&In-Reply-To=&lt;200001170940.EAA09717@mail4.lig.bellsouth.net&gt;">bradbury@ilr.genebee.msu.su</A> (Robert J. Bradbury)
<BR>
To:             	<A HREF="mailto:extropians@extropy.org?Subject=Re:%20Pleconaril&In-Reply-To=&lt;200001170940.EAA09717@mail4.lig.bellsouth.net&gt;">extropians@extropy.org</A>
<BR>
Date sent:      	Mon, 17 Jan 2000 11:41 EST
<BR>
Subject:        	Pleconaril
<BR>
Send reply to:  	<A HREF="mailto:extropians@extropy.com?Subject=Re:%20Pleconaril&In-Reply-To=&lt;200001170940.EAA09717@mail4.lig.bellsouth.net&gt;">extropians@extropy.com</A>
<BR>
<P><EM>&gt; 
</EM><BR>
<EM>&gt; From: <A HREF="http://www.viropharma.com/Pipeline/Pleconaril.htm">http://www.viropharma.com/Pipeline/Pleconaril.htm</A>
</EM><BR>
<EM>&gt; 
</EM><BR>
<EM>&gt; &gt; Pleconaril is a member of a class of compounds that inhibit
</EM><BR>
<EM>&gt; &gt; capsid function of picornaviruses. The capsid is essential for a
</EM><BR>
<EM>&gt; &gt; virus to infect healthy cells. These compounds integrate into a
</EM><BR>
<EM>&gt; &gt; hydrophobic pocket within the virus and interrupt the replication cycle.
</EM><BR>
<EM>&gt; 
</EM><BR>
<EM>&gt; This is a little vague, but it seems like it prevents the virus from
</EM><BR>
<EM>&gt; opening up to release the RNA (not by interfering with receptor binding
</EM><BR>
<EM>&gt; as I believe some drugs coming out of Australia are supposed to do).
</EM><BR>
<EM>&gt; 
</EM><BR>
<EM>&gt; If this works, then minor variants in the drug design could produce
</EM><BR>
<EM>&gt; molecules that work against all viruses that &quot;decloak&quot; via similar
</EM><BR>
<EM>&gt; mechanisms and have substantively similar capsid structures.  While
</EM><BR>
<EM>&gt; as was pointed out, the capsid outer surfaces may vary, the interlocking
</EM><BR>
<EM>&gt; faces of the capsid sub-components cannot (without disrupting the
</EM><BR>
<EM>&gt; self-assembly or disassembly function).  So if they have a &quot;lock&quot;
</EM><BR>
<EM>&gt; that binds the faces together (my best impression from their pictures),
</EM><BR>
<EM>&gt; then this would seem to be a generally good method for suppressing
</EM><BR>
<EM>&gt; the replication of the virus.
</EM><BR>
<EM>&gt; 
</EM><BR>
<EM>&gt; Science at its finest.  This gets my vote for the sexiest breakthrough
</EM><BR>
<EM>&gt; so far in the new millennium.  Its up there with the trojan horse
</EM><BR>
<EM>&gt; strategy against HIV that was announced last year.
</EM><BR>
<EM>&gt; 
</EM><BR>
<EM>&gt; Robert
</EM><BR>
<EM>&gt; 
</EM><BR>
This regular geometric solid shape interests me.  There are only 
<BR>
five regular solids (discounting spheres).  I do not think that, for 
<BR>
reasons of surface-to-volume ratio and the tendency of points and 
<BR>
edges to get hung up, hindering mobility, that tetrahedrons, 
<BR>
octahedrons and cubes are good candidate shapes.  The 
<BR>
picornaviruses are icosahedral.  I wonder if there are 
<BR>
dodecahedrally shaped viruses, and if so, to which diseases they 
<BR>
might belong?
<BR>
<P><!-- body="end" -->
<HR NOSHADE>
<UL>
<!-- next="start" -->
<LI><STRONG>Next message:</STRONG> <A HREF="0883.html">Anders Sandberg: "Re: Creating new states"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="0881.html">Robert J. Bradbury: "Pleconaril"</A>
<LI><STRONG>In reply to:</STRONG> <A HREF="0881.html">Robert J. Bradbury: "Pleconaril"</A>
<!-- nextthread="start" -->
<LI><STRONG>Next in thread:</STRONG> <A HREF="0904.html">Eliezer S. Yudkowsky: "Re: Pleconaril"</A>
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#882">[ date ]</A>
<A HREF="index.html#882">[ thread ]</A>
<A HREF="subject.html#882">[ subject ]</A>
<A HREF="author.html#882">[ author ]</A>
</UL>
<!-- trailer="footer" -->
<HR NOSHADE>
<P>
<SMALL>
<EM>
This archive was generated by <A HREF="http://www.hypermail.org/">hypermail 2b29</A> 
: <EM>Thu Jul 27 2000 - 14:02:20 MDT</EM>
</EM>
</SMALL>
</BODY>
</HTML>
